Joanna C. Evans

752 total citations
19 papers, 481 citations indexed

About

Joanna C. Evans is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, Joanna C. Evans has authored 19 papers receiving a total of 481 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 10 papers in Molecular Biology and 10 papers in Epidemiology. Recurrent topics in Joanna C. Evans's work include Tuberculosis Research and Epidemiology (15 papers), Mycobacterium research and diagnosis (10 papers) and Neurological diseases and metabolism (5 papers). Joanna C. Evans is often cited by papers focused on Tuberculosis Research and Epidemiology (15 papers), Mycobacterium research and diagnosis (10 papers) and Neurological diseases and metabolism (5 papers). Joanna C. Evans collaborates with scholars based in South Africa, United Kingdom and United States. Joanna C. Evans's co-authors include Valerie Mizrahi, Heidi Segal, Mark P. Nicol, Digby F. Warner, Dhirendra Govender, Robert J. Wilkinson, Lafras M. Steyn, Kyu Y. Rhee, Carolina Trujillo and Jonathan M. Blackburn and has published in prestigious journals such as Angewandte Chemie International Edition, Biochemistry and Clinical Infectious Diseases.

In The Last Decade

Joanna C. Evans

18 papers receiving 476 citations

Peers

Joanna C. Evans

EPIDE

SURGE

Priya Ragunathan Singapore

Suzana Savvi South Africa

Wonsik Lee United States

Suresh Solapure India

Jickky Palmae Sarathy United States

Manchi C. M. Reddy United States

H. M. Adnan Hameed China

Allen Casey United States

Mariama C. Maiga United States

Tamara Hess United States

Priya Ragunathan Singapore

Joanna C. Evans

262 ×0.7

141 ×0.5

EPIDE

468 ×2.1

42 ×0.4

SURGE

31 ×0.7

Citations per year, relative to Joanna C. Evans Joanna C. Evans (= 1×) peers Priya Ragunathan

Countries citing papers authored by Joanna C. Evans

Since Specialization

Citations

This map shows the geographic impact of Joanna C. Evans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joanna C. Evans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joanna C. Evans more than expected).

Fields of papers citing papers by Joanna C. Evans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joanna C. Evans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joanna C. Evans. The network helps show where Joanna C. Evans may publish in the future.

Co-authorship network of co-authors of Joanna C. Evans

This figure shows the co-authorship network connecting the top 25 collaborators of Joanna C. Evans. A scholar is included among the top collaborators of Joanna C. Evans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joanna C. Evans. Joanna C. Evans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Wang, Xu, Deon P. Neveling, Joanna C. Evans, et al.. (2025). Metabolic Activation versus Masked Prodrugs: Bisubstrate Mimic Inhibitors of CoaBC’s PPCS Activity in Mycobacterium tuberculosis and Staphylococcus aureus. ACS Infectious Diseases. 11(6). 1508–1517.

Bakali, Jamal El, M. Błaszczyk, Joanna C. Evans, et al.. (2023). Chemical Validation of Mycobacterium tuberculosis Phosphopantetheine Adenylyltransferase Using Fragment Linking and CRISPR Interference**. Angewandte Chemie International Edition. 62(17). e202300221–e202300221. 8 indexed citations

Bakali, Jamal El, M. Błaszczyk, Joanna C. Evans, et al.. (2023). Chemical Validation of Mycobacterium tuberculosis Phosphopantetheine Adenylyltransferase Using Fragment Linking and CRISPR Interference**. Angewandte Chemie. 135(17). e202300221–e202300221. 1 indexed citations

Ferlenghi, Francesca, Giannamaria Annunziato, Giulia Degiacomi, et al.. (2022). Expanding the knowledge around antitubercular 5-(2-aminothiazol-4-yl)isoxazole-3-carboxamides: Hit–to–lead optimization and release of a novel antitubercular chemotype via scaffold derivatization. European Journal of Medicinal Chemistry. 245(Pt 2). 114916–114916. 9 indexed citations

Evans, Joanna C., John Post, V. Mendes, et al.. (2021). Targeting Mycobacterium tuberculosis CoaBC through Chemical Inhibition of 4′-Phosphopantothenoyl-l-cysteine Synthetase (CoaB) Activity. ACS Infectious Diseases. 7(6). 1666–1679. 6 indexed citations

Ganapathy, Uday S., Tian Lan, Philipp Krastel, et al.. (2021). Blocking Bacterial Naphthohydroquinone Oxidation and ADP-Ribosylation Improves Activity of Rifamycins against Mycobacterium abscessus. Antimicrobial Agents and Chemotherapy. 65(9). e0097821–e0097821. 18 indexed citations

Mougari, Faïza, D Chopin, Anne‐Lise Munier, et al.. (2019). Prospective study comparing the conventional and same-day strategies to diagnose pulmonary tuberculosis. Médecine et Maladies Infectieuses. 50(1). 36–42. 1 indexed citations

Tanner, Lloyd, Joanna C. Evans, Ronnett Seldon, et al.. (2019). In Vitro Efficacies, ADME, and Pharmacokinetic Properties of Phenoxazine Derivatives Active against Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy. 63(11). 25 indexed citations

Evans, Joanna C. & Valerie Mizrahi. (2018). Priming the tuberculosis drug pipeline: new antimycobacterial targets and agents. Current Opinion in Microbiology. 45. 39–46. 30 indexed citations

10.

Koch, Anastasia, Daniela Brites, David Stucki, et al.. (2017). The Influence of HIV on the Evolution of Mycobacterium tuberculosis. Molecular Biology and Evolution. 34(7). 1654–1668. 14 indexed citations

11.

Evans, Joanna C., Carolina Trujillo, Zhe Wang, et al.. (2016). Validation of CoaBC as a Bactericidal Target in the Coenzyme A Pathway of Mycobacterium tuberculosis. ACS Infectious Diseases. 2(12). 958–968. 56 indexed citations

12.

Evans, Joanna C. & Valerie Mizrahi. (2015). The application of tetracyclineregulated gene expression systems in the validation of novel drug targets in Mycobacterium tuberculosis. Frontiers in Microbiology. 6. 812–812. 31 indexed citations

13.

Singh, Vinayak, Raju Mukherjee, Joanna C. Evans, et al.. (2014). The Complex Mechanism of Antimycobacterial Action of 5-Fluorouracil. Chemistry & Biology. 22(1). 63–75. 71 indexed citations

14.

Wei, Yin, Leonardo Martinelli, Joanna C. Evans, et al.. (2014). Reaction intermediate analogues as bisubstrate inhibitors of pantothenate synthetase. Bioorganic & Medicinal Chemistry. 22(5). 1726–1735. 17 indexed citations

15.

Warner, Digby F., Joanna C. Evans, & Valerie Mizrahi. (2014). Nucleotide Metabolism and DNA Replication. Microbiology Spectrum. 2(5). 28 indexed citations

16.

Evans, Joanna C. & Heidi Segal. (2010). Novel multiplex allele-specific PCR assays for the detection of resistance to second-line drugs in Mycobacterium tuberculosis. Journal of Antimicrobial Chemotherapy. 65(5). 897–900. 35 indexed citations

17.

Govender, Dhirendra, et al.. (2008). Recent and Rapid Emergence of W‐Beijing Strains of Mycobacterium tuberculosis in Cape Town, South Africa. Clinical Infectious Diseases. 47(10). 1252–1259. 92 indexed citations

18.

Evans, Joanna C., et al.. (2008). Rapid genotypic assays to identify drug-resistant Mycobacterium tuberculosis in South Africa. Journal of Antimicrobial Chemotherapy. 63(1). 11–16. 32 indexed citations

19.

Glick, David, Martin J. Valler, Christopher C. Rowlands, Joanna C. Evans, & John Kay. (1982). Activation of spin-labeled chicken pepsinogen. Biochemistry. 21(16). 3746–3750. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact